The scopolamine model as a pharmacodynamic marker in early drug development

The price of innovation: new estimates of drug development costs

Joseph A. DiMasi, Ronald W. Hansen, Henry G. Grabowski · Journal of Health Economics · 2003 · 4.3K citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacoeconomics +14

Donepezil Improves Cognition and Global Function in Alzheimer Disease<subtitle>A 15-Week, Double-blind, Placebo-Controlled Study</subtitle>

Sharon L. Rogers · Archives of Internal Medicine · 1998 · 778 citations

Medicine, Pharmacology, Pharmacotherapy +16

The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers

Keith Wesnes, Tony Ward, Ann McGinty et al. · Psychopharmacology · 2000 · 304 citations

Social Sciences, Psychology, Memory +5

Distinct contributions of glutamate and dopamine receptors to temporal aspects of rodent working memory using a clinically relevant task

Julie M. Aultman, Bita Moghaddam · Psychopharmacology · 2000 · 215 citations

Life Sciences, Neurobiology, Neuroscience +15

Caffeine attenuates scopolamine-induced memory impairment in humans

W. Reidel, Eef Hogervorst, R.L.A.M. Leboux et al. · Psychopharmacology · 1995 · 153 citations · Full text

Medicine, Neuroscience, Pharmacology +12